Baxter International Inc. (BAX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
79.38+0.55 (+0.70%)
As of 12:59PM EST. Market open.
| Previous close | 78.83 |
| Open | 78.66 |
| Bid | 79.33 x 800 |
| Ask | 79.37 x 800 |
| Day's range | 78.52 - 79.75 |
| 52-week range | 69.10 - 95.19 |
| Volume | 1,089,597 |
| Avg. volume | 3,135,783 |
| Market cap | 40.549B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | 44.92 |
| EPS (TTM) | 1.77 |
| Earnings date | 04 Feb 2021 |
| Forward dividend & yield | 0.98 (1.22%) |
| Ex-dividend date | 03 Dec 2020 |
| 1y target est | 93.71 |
- Zacks
Baxter (BAX) Inks Sterile Manufacturing Agreement With Novavax
Baxter's (BAX) BioPharma Solutions business inks deal to advance commercial-scale production and increase access for the COVID-19 vaccine in the U.K. and European markets.
- Business Wire
Baxter Biopharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
Baxter BioPharma Solutions announced an agreement with Novavax to provide sterile manufacturing services for its COVID-19 vaccine candidate.
- Business Wire
Baxter to Host Fourth-Quarter 2020 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thursday, February 4, 2021 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/5044187 to pre-register for the call and receive the call information.
© 2021 Verizon Media. All rights reserved.
